# IOMERVU
> **NDA216016** · New Drug Application · Sponsor: BRACCO · Approved 2024-11-27
## Drug
- **FDA Application Number:** NDA216016
- **Application type:** New Drug Application
- **Brand name:** IOMERVU
- **Generic name:** IOMEPROL INJECTION
- **Active ingredients:** IOMEPROL
- **Dosage form:** SOLUTION
- **Route:** INTRA-ARTERIAL
- **Marketing status:** Discontinued
- **Sponsor:** BRACCO
- **Manufacturer:** BRACCO DIAGNOSTICS INC
- **First approval:** 2024-11-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216016)
---
*AI Analytics · CC0 1.0*